10-(3-indazol-1-ylbenzene-2-id-1-yl)-2-pyrazol-1-yl-1H-phenoxazin-1-ide;10-(3-indazol-1-ylbenzene-2-id-1-yl)-2-pyridin-2-yl-1H-phenoxazin-1-ide;2-indazol-1-yl-10-(3-pyrazol-1-ylbenzene-2-id-1-yl)-1H-phenoxazin-1-ide;2-indazol-1-yl-10-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-phenoxazin-1-ide;tetrakis(platinum(2+))

C116H70N18O4Pt4 — CID 158348078

IUPAC10-(3-indazol-1-ylbenzene-2-id-1-yl)-2-pyrazol-1-yl-1H-phenoxazin-1-ide;10-(3-indazol-1-ylbenzene-2-id-1-yl)-2-pyridin-2-yl-1H-phenoxazin-1-ide;2-indazol-1-yl-10-(3-pyrazol-1-ylbenzene-2-id-1-yl)-1H-phenoxazin-1-ide;2-indazol-1-yl-10-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-phenoxazin-1-ide;tetrakis(platinum(2+))
SMILES[Pt+2].[Pt+2].[Pt+2].[Pt+2].[c-]1c(-c2ccccn2)cccc1N1c2[c-]c(-n3ncc4ccccc43)ccc2Oc2ccccc21.[c-]1c(N2c3[c-]c(-c4ccccn4)ccc3Oc3ccccc32)cccc1-n1ncc2ccccc21.[c-]1c(N2c3[c-]c(-n4cccn4)ccc3Oc3ccccc32)cccc1-n1ncc2ccccc21.[c-]1c(N2c3[c-]c(-n4ncc5ccccc54)ccc3Oc3ccccc32)cccc1-n1cccn1
InChIInChI=1S/2C30H18N4O.2C28H17N5O.4Pt/c1-2-12-26-22(8-1)20-32-34(26)24-10-7-9-23(19-24)33-27-13-3-4-14-29(27)35-30-16-15-21(18-28(30)33)25-11-5-6-17-31-25;1-2-12-26-22(8-1)20-32-34(26)24-15-16-30-28(19-24)33(27-13-3-4-14-29(27)35-30)23-10-7-9-21(18-23)25-11-5-6-17-31-25;1-2-10-24-20(7-1)19-30-33(24)23-9-5-8-22(17-23)32-25-11-3-4-12-27(25)34-28-14-13-21(18-26(28)32)31-16-6-15-29-31;1-2-10-24-20(7-1)19-30-33(24)23-13-14-28-26(18-23)32(25-11-3-4-12-27(25)34-28)22-9-5-8-21(17-22)31-16-6-15-29-31;;;;/h2*1-17,20H;2*1-16,19H;;;;/q4*-2;4*+2
InChIKeyFKPMESWQMXSONZ-UHFFFAOYSA-N
MW2560.27 g/mol
LogP27.29
Rot. Bonds12

About 10-(3-indazol-1-ylbenzene-2-id-1-yl)-2-pyrazol-1-yl-1H-phenoxazin-1-ide;10-(3-indazol-1-ylbenzene-2-id-1-yl)-2-pyridin-2-yl-1H-phenoxazin-1-ide;2-indazol-1-yl-10-(3-pyrazol-1-ylbenzene-2-id-1-yl)-1H-phenoxazin-1-ide;2-indazol-1-yl-10-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-phenoxazin-1-ide;tetrakis(platinum(2+))

10-(3-indazol-1-ylbenzene-2-id-1-yl)-2-pyrazol-1-yl-1H-phenoxazin-1-ide;10-(3-indazol-1-ylbenzene-2-id-1-yl)-2-pyridin-2-yl-1H-phenoxazin-1-ide;2-indazol-1-yl-10-(3-pyrazol-1-ylbenzene-2-id-1-yl)-1H-phenoxazin-1-ide;2-indazol-1-yl-10-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-phenoxazin-1-ide;tetrakis(platinum(2+)) (PubChem CID 158348078) has the molecular formula C116H70N18O4Pt4 and a molecular weight of 2560.27 g/mol. Its IUPAC name is 10-(3-indazol-1-ylbenzene-2-id-1-yl)-2-pyrazol-1-yl-1H-phenoxazin-1-ide;10-(3-indazol-1-ylbenzene-2-id-1-yl)-2-pyridin-2-yl-1H-phenoxazin-1-ide;2-indazol-1-yl-10-(3-pyrazol-1-ylbenzene-2-id-1-yl)-1H-phenoxazin-1-ide;2-indazol-1-yl-10-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-phenoxazin-1-ide;tetrakis(platinum(2+)).

Molecular Properties

Compound Name10-(3-indazol-1-ylbenzene-2-id-1-yl)-2-pyrazol-1-yl-1H-phenoxazin-1-ide;10-(3-indazol-1-ylbenzene-2-id-1-yl)-2-pyridin-2-yl-1H-phenoxazin-1-ide;2-indazol-1-yl-10-(3-pyrazol-1-ylbenzene-2-id-1-yl)-1H-phenoxazin-1-ide;2-indazol-1-yl-10-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-phenoxazin-1-ide;tetrakis(platinum(2+))
PubChem CID158348078
Molecular FormulaC116H70N18O4Pt4
Molecular Weight2560.27 g/mol
Exact Mass2558.44
IUPAC Name10-(3-indazol-1-ylbenzene-2-id-1-yl)-2-pyrazol-1-yl-1H-phenoxazin-1-ide;10-(3-indazol-1-ylbenzene-2-id-1-yl)-2-pyridin-2-yl-1H-phenoxazin-1-ide;2-indazol-1-yl-10-(3-pyrazol-1-ylbenzene-2-id-1-yl)-1H-phenoxazin-1-ide;2-indazol-1-yl-10-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-phenoxazin-1-ide;tetrakis(platinum(2+))
SMILES[Pt+2].[Pt+2].[Pt+2].[Pt+2].[c-]1c(-c2ccccn2)cccc1N1c2[c-]c(-n3ncc4ccccc43)ccc2Oc2ccccc21.[c-]1c(N2c3[c-]c(-c4ccccn4)ccc3Oc3ccccc32)cccc1-n1ncc2ccccc21.[c-]1c(N2c3[c-]c(-n4cccn4)ccc3Oc3ccccc32)cccc1-n1ncc2ccccc21.[c-]1c(N2c3[c-]c(-n4ncc5ccccc54)ccc3Oc3ccccc32)cccc1-n1cccn1
InChIInChI=1S/2C30H18N4O.2C28H17N5O.4Pt/c1-2-12-26-22(8-1)20-32-34(26)24-10-7-9-23(19-24)33-27-13-3-4-14-29(27)35-30-16-15-21(18-28(30)33)25-11-5-6-17-31-25;1-2-12-26-22(8-1)20-32-34(26)24-15-16-30-28(19-24)33(27-13-3-4-14-29(27)35-30)23-10-7-9-21(18-23)25-11-5-6-17-31-25;1-2-10-24-20(7-1)19-30-33(24)23-9-5-8-22(17-23)32-25-11-3-4-12-27(25)34-28-14-13-21(18-26(28)32)31-16-6-15-29-31;1-2-10-24-20(7-1)19-30-33(24)23-13-14-28-26(18-23)32(25-11-3-4-12-27(25)34-28)22-9-5-8-21(17-22)31-16-6-15-29-31;;;;/h2*1-17,20H;2*1-16,19H;;;;/q4*-2;4*+2
InChIKeyFKPMESWQMXSONZ-UHFFFAOYSA-N
XLogP27.29
TPSA182.58 Ų
H-Bond Donors
H-Bond Acceptors22
Rotatable Bonds12
Heavy Atoms142
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002560.27
LogP ≤ 527.29
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1022

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Carbo_cation/anion', 'substructure': 'N/A'}

Analyze 10-(3-indazol-1-ylbenzene-2-id-1-yl)-2-pyrazol-1-yl-1H-phenoxazin-1-ide;10-(3-indazol-1-ylbenzene-2-id-1-yl)-2-pyridin-2-yl-1H-phenoxazin-1-ide;2-indazol-1-yl-10-(3-pyrazol-1-ylbenzene-2-id-1-yl)-1H-phenoxazin-1-ide;2-indazol-1-yl-10-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-phenoxazin-1-ide;tetrakis(platinum(2+)) with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 10-(3-indazol-1-ylbenzene-2-id-1-yl)-2-pyrazol-1-yl-1H-phenoxazin-1-ide;10-(3-indazol-1-ylbenzene-2-id-1-yl)-2-pyridin-2-yl-1H-phenoxazin-1-ide;2-indazol-1-yl-10-(3-pyrazol-1-ylbenzene-2-id-1-yl)-1H-phenoxazin-1-ide;2-indazol-1-yl-10-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-phenoxazin-1-ide;tetrakis(platinum(2+))?
The IUPAC name of 10-(3-indazol-1-ylbenzene-2-id-1-yl)-2-pyrazol-1-yl-1H-phenoxazin-1-ide;10-(3-indazol-1-ylbenzene-2-id-1-yl)-2-pyridin-2-yl-1H-phenoxazin-1-ide;2-indazol-1-yl-10-(3-pyrazol-1-ylbenzene-2-id-1-yl)-1H-phenoxazin-1-ide;2-indazol-1-yl-10-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-phenoxazin-1-ide;tetrakis(platinum(2+)) (CID 158348078) is 10-(3-indazol-1-ylbenzene-2-id-1-yl)-2-pyrazol-1-yl-1H-phenoxazin-1-ide;10-(3-indazol-1-ylbenzene-2-id-1-yl)-2-pyridin-2-yl-1H-phenoxazin-1-ide;2-indazol-1-yl-10-(3-pyrazol-1-ylbenzene-2-id-1-yl)-1H-phenoxazin-1-ide;2-indazol-1-yl-10-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-phenoxazin-1-ide;tetrakis(platinum(2+)).
What is the SMILES notation for 10-(3-indazol-1-ylbenzene-2-id-1-yl)-2-pyrazol-1-yl-1H-phenoxazin-1-ide;10-(3-indazol-1-ylbenzene-2-id-1-yl)-2-pyridin-2-yl-1H-phenoxazin-1-ide;2-indazol-1-yl-10-(3-pyrazol-1-ylbenzene-2-id-1-yl)-1H-phenoxazin-1-ide;2-indazol-1-yl-10-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-phenoxazin-1-ide;tetrakis(platinum(2+))?
The canonical SMILES for 10-(3-indazol-1-ylbenzene-2-id-1-yl)-2-pyrazol-1-yl-1H-phenoxazin-1-ide;10-(3-indazol-1-ylbenzene-2-id-1-yl)-2-pyridin-2-yl-1H-phenoxazin-1-ide;2-indazol-1-yl-10-(3-pyrazol-1-ylbenzene-2-id-1-yl)-1H-phenoxazin-1-ide;2-indazol-1-yl-10-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-phenoxazin-1-ide;tetrakis(platinum(2+)) is [Pt+2].[Pt+2].[Pt+2].[Pt+2].[c-]1c(-c2ccccn2)cccc1N1c2[c-]c(-n3ncc4ccccc43)ccc2Oc2ccccc21.[c-]1c(N2c3[c-]c(-c4ccccn4)ccc3Oc3ccccc32)cccc1-n1ncc2ccccc21.[c-]1c(N2c3[c-]c(-n4cccn4)ccc3Oc3ccccc32)cccc1-n1ncc2ccccc21.[c-]1c(N2c3[c-]c(-n4ncc5ccccc54)ccc3Oc3ccccc32)cccc1-n1cccn1.
What is the InChIKey of 10-(3-indazol-1-ylbenzene-2-id-1-yl)-2-pyrazol-1-yl-1H-phenoxazin-1-ide;10-(3-indazol-1-ylbenzene-2-id-1-yl)-2-pyridin-2-yl-1H-phenoxazin-1-ide;2-indazol-1-yl-10-(3-pyrazol-1-ylbenzene-2-id-1-yl)-1H-phenoxazin-1-ide;2-indazol-1-yl-10-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-phenoxazin-1-ide;tetrakis(platinum(2+))?
The InChIKey is FKPMESWQMXSONZ-UHFFFAOYSA-N. The full InChI is InChI=1S/2C30H18N4O.2C28H17N5O.4Pt/c1-2-12-26-22(8-1)20-32-34(26)24-10-7-9-23(19-24)33-27-13-3-4-14-29(27)35-30-16-15-21(18-28(30)33)25-11-5-6-17-31-25;1-2-12-26-22(8-1)20-32-34(26)24-15-16-30-28(19-24)33(27-13-3-4-14-29(27)35-30)23-10-7-9-21(18-23)25-11-5-6-17-31-25;1-2-10-24-20(7-1)19-30-33(24)23-9-5-8-22(17-23)32-25-11-3-4-12-27(25)34-28-14-13-21(18-26(28)32)31-16-6-15-29-31;1-2-10-24-20(7-1)19-30-33(24)23-13-14-28-26(18-23)32(25-11-3-4-12-27(25)34-28)22-9-5-8-21(17-22)31-16-6-15-29-31;;;;/h2*1-17,20H;2*1-16,19H;;;;/q4*-2;4*+2.
What are the key properties of 10-(3-indazol-1-ylbenzene-2-id-1-yl)-2-pyrazol-1-yl-1H-phenoxazin-1-ide;10-(3-indazol-1-ylbenzene-2-id-1-yl)-2-pyridin-2-yl-1H-phenoxazin-1-ide;2-indazol-1-yl-10-(3-pyrazol-1-ylbenzene-2-id-1-yl)-1H-phenoxazin-1-ide;2-indazol-1-yl-10-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-phenoxazin-1-ide;tetrakis(platinum(2+))?
10-(3-indazol-1-ylbenzene-2-id-1-yl)-2-pyrazol-1-yl-1H-phenoxazin-1-ide;10-(3-indazol-1-ylbenzene-2-id-1-yl)-2-pyridin-2-yl-1H-phenoxazin-1-ide;2-indazol-1-yl-10-(3-pyrazol-1-ylbenzene-2-id-1-yl)-1H-phenoxazin-1-ide;2-indazol-1-yl-10-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-phenoxazin-1-ide;tetrakis(platinum(2+)) has a molecular weight of 2560.27 g/mol, XLogP of 27.29, 12 rotatable bonds, 0 hydrogen bond donors, and 22 hydrogen bond acceptors.
Where does this data come from?
All data for 10-(3-indazol-1-ylbenzene-2-id-1-yl)-2-pyrazol-1-yl-1H-phenoxazin-1-ide;10-(3-indazol-1-ylbenzene-2-id-1-yl)-2-pyridin-2-yl-1H-phenoxazin-1-ide;2-indazol-1-yl-10-(3-pyrazol-1-ylbenzene-2-id-1-yl)-1H-phenoxazin-1-ide;2-indazol-1-yl-10-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-phenoxazin-1-ide;tetrakis(platinum(2+)) is sourced from PubChem (CID 158348078), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).